[HTML][HTML] Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - Cancers, 2021 - mdpi.com
Simple Summary A subset of colorectal cancers (CRCs) is characterized by a mismatch
repair deficiency that is frequently associated with microsatellite instability (MSI). The …
repair deficiency that is frequently associated with microsatellite instability (MSI). The …
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers
V Amodio, G Mauri, NM Reilly, A Sartore-bianchi… - CANCERS, 2021 - iris.unito.it
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
[HTML][HTML] Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - Cancers, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
[PDF][PDF] Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers. Cancers 2021 …
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - 2021 - pdfs.semanticscholar.org
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - Cancers, 2021 - europepmc.org
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - …, 2021 - search.ebscohost.com
Simple Summary: A subset of colorectal cancers (CRCs) is characterized by a mismatch
repair deficiency that is frequently associated with microsatellite instability (MSI). The …
repair deficiency that is frequently associated with microsatellite instability (MSI). The …
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - …, 2021 - search.proquest.com
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
V Amodio, G Mauri, NM Reilly… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers
V Amodio, G Mauri, NM Reilly, A Sartore Bianchi… - CANCERS, 2021 - air.unimi.it
Immune checkpoint inhibitors (CPIs) represent an effective therapeutic strategy for several
different types of solid tumors and are remarkably effective in mismatch repair deficient …
different types of solid tumors and are remarkably effective in mismatch repair deficient …
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi… - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Immune checkpoint inhibitors (CPIs) represent an effective therapeutic
strategy for several different types of solid tumors and are remarkably effective in mismatch …
strategy for several different types of solid tumors and are remarkably effective in mismatch …